- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Delaying frozen embryo transfer for six months after preceding pregnancy loss improves pregnancy outcomes
When it comes to the interpregnancy interval (IPI) following a clinical pregnancy loss (CPL) during in vitro fertilization (IVF) treatment, finding the right timing has remained a subject of debate. A recent retrospective cohort study conducted in China aimed to shed light on this matter by evaluating the association between various IPI lengths and the outcomes of the next frozen embryo transfer (FET). This study suggests that the timing of the interpregnancy interval is a crucial factor in achieving successful pregnancy outcomes, particularly for women undergoing IVF treatment after experiencing a clinical pregnancy loss.
This study was published in JAMA Network Open by Ze Wang and colleagues. This was a retrospective cohort study conducted at the Center for Reproductive Medicine of Shandong University in China. The study aimed to evaluate the association between different interpregnancy interval (IPI) lengths following a preceding clinical pregnancy loss (CPL) and the subsequent pregnancy outcomes of the next frozen embryo transfer (FET).
The study included women who had undergone frozen-thawed blastocyst transfer within 1 year after experiencing a CPL during in vitro fertilization (IVF) treatment. The data were collected from women who received IVF treatment between July 1, 2017, and June 30, 2022. Follow-up for pregnancy outcomes was completed for all participants on March 31, 2023.
The study included a total of 2433 women with a mean age of 31.8 years. These women were divided into three groups based on the length of their interpregnancy interval following a CPL: less than 3 months, 3 to less than 6 months, and 6 to 12 months. The study assessed several key pregnancy outcomes related to the next FET after a preceding CPL. These outcomes included:
Clinical Pregnancy: The achievement of a clinical pregnancy following the FET.
Live Birth: The successful delivery of a live infant following the FET.
Healthy Live Birth: The delivery of a live infant without adverse health conditions.
Total Pregnancy Loss: The occurrence of pregnancy loss, including both clinical and subclinical losses.
The outcomes were evaluated by calculating adjusted odds ratios (AORs) to determine the association between the length of interpregnancy intervals and these pregnancy outcomes. The study focused on comparing the outcomes between women with shorter IPIs (<3 and 3 to <6 months) and those with an IPI of 6 to 12 months.
Compared with women with an IPI of 6 to 12 months, those with shorter IPIs (<3 and 3 to <6 months) had the following results:
Clinical Pregnancy:
An IPI of less than 3 months: Adjusted Odds Ratio (AOR) of 0.70 (95% CI: 0.53-0.92)
An IPI of 3 to less than 6 months: AOR of 0.79 (95% CI: 0.65-0.95)
Live Birth:
An IPI of less than 3 months: AOR of 0.64 (95% CI: 0.48-0.85)
An IPI of 3 to less than 6 months: AOR of 0.74 (95% CI: 0.61-0.90)
Healthy Live Birth:
An IPI of less than 3 months: AOR of 0.63 (95% CI: 0.46-0.87)
An IPI of 3 to less than 6 months: AOR of 0.79 (95% CI: 0.64-0.98)
Total Pregnancy Loss:
An IPI of less than 3 months: AOR of 1.87 (95% CI: 1.31-2.67)
An IPI of 3 to less than 6 months: AOR of 1.29 (95% CI: 1.00-1.66)
These results indicate that shorter interpregnancy intervals (<3 and 3 to <6 months) were associated with a decreased likelihood of achieving clinical pregnancy, live birth, and healthy live birth. Additionally, women with shorter IPIs had a higher risk of total pregnancy loss compared to those with an IPI of 6 to 12 months.
Delaying the next frozen embryo transfer for at least 6 months after a preceding clinical pregnancy loss was found to be associated with more favorable pregnancy outcomes, emphasizing the significance of interpregnancy interval length in the context of IVF treatment following a CPL. Further prospective studies are warranted to validate and expand upon these findings.
Reference:Wang, Z., Meng, Y., Shang, X., Suo, L., Zhao, D., Han, X., Yang, M., Yin, M., Miao, H., Wang, Y., Yang, H., Yu, Y., Wei, D., & Chen, Z.-J. Interpregnancy interval after clinical pregnancy loss and outcomes of the next frozen embryo transfer. JAMA Network Open,2023;6(10):e2340709. https://doi.org/10.1001/jamanetworkopen.2023.40709
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751